ClinicalTrials.gov
ClinicalTrials.gov Menu

Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03148275
Recruitment Status : Suspended (Other - Pending protocol amendment)
First Posted : May 10, 2017
Last Update Posted : October 9, 2018
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : December 31, 2023
  Estimated Study Completion Date : December 31, 2023